Table 1.
Demographic and clinical data of the sample.
| DCP | SCP | HC | P value | |
|---|---|---|---|---|
| Number of participants (N) | 16 | 18 | 18 | |
| Age (mean years ± std) | 9.6 ± 5.0 | 8.9 ± 3.1 | 9.5 ± 2.2 | 0.818 |
| Gender | 10 M, 6 F | 10 M, 8 F | 11 M, 7 F | 0.907 |
| GMFCS | II: 3, III: 7, IV: 5, V: 1 | I: 9, II: 5, III: 4 | 0.003 | |
| ADL (mean scores ± std) | 38.44 ± 18 | 82.55 ± 3.4 | <0.001 | |
| Neuroimage finding (N) | ||||
| White matter lesion | 6 | 15 | ||
| Cortical gray matter abnormality | 1 | 0 | ||
| Basal ganglia/thalamus abnormality | 3 | 1 | ||
| Normal (N) | 6 | 2 | ||
M: male; F: female; std: standard deviation; N: number of participants. P value: comparisons for age and gender among the three groups: the variable gender was analyzed using chi-square test, while the age was analyzed using ANOVA; comparisons for GMFCS and ADL between DCP and SCP: the variable GMFCS was analyzed using chi-square test, while the ADL were analyzed using two-sample t-test.